Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantationRichard F. Schlenk, Konstanze Döhner, Gerhard Held et al.|Blood|2014Cited by 400
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)Nicolaus Kröger, Théo de Witte, Simona Iacobelli et al.|Journal of Clinical Oncology|2017Cited by 248
A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myelomaIngmar Bruns, Guido Kobbe, Ulrich Steidl et al.|Transfusion|2005Cited by 68